Disc Medicine, Inc.
IRON
$77.44
$0.000.00%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -69.13% | -107.40% | -94.03% | -75.02% | -59.76% |
| Total Depreciation and Amortization | 184.00% | 133.33% | 80.13% | 16.86% | -32.80% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 173.12% | 191.44% | 132.35% | 111.70% | 58.02% |
| Change in Net Operating Assets | 242.86% | 89.87% | 9.13% | -159.97% | -162.65% |
| Cash from Operations | -47.16% | -97.88% | -92.06% | -95.68% | -80.74% |
| Capital Expenditure | 96.54% | 93.64% | -84.75% | -2,208.47% | -1,085.71% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 68.04% | 88.77% | -34.79% | 41.05% | -32.94% |
| Cash from Investing | 68.17% | 88.78% | -34.88% | 40.59% | -33.47% |
| Total Debt Issued | 3.42% | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -4.11% | -44.80% | 140.84% | 25.99% | 20.28% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -41.32% | -41.32% | 1,110.48% | -- | 13,881.03% |
| Cash from Financing | -4.40% | -48.32% | 116.85% | 44.74% | 39.05% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 81.31% | 84.65% | 39.69% | 70.77% | -58.36% |